Fluorescein Diacetate Microplate Assay in Cell Viability Detection

Area of Science:

• Cell Biology
• Biochemistry
• Assay Development

Background:

• Cell viability assays are crucial for drug discovery and toxicology.
• The methyl thiazolyl (MTT) assay is widely used but has limitations.
• There is a need for alternative, sensitive, and stable cell viability detection methods.

Purpose of the Study:

• To evaluate the application and optimize the conditions for the fluorescein diacetate (FDA) microplate assay.
• To compare the performance of the FDA assay with the MTT assay for cell viability and H2O2-induced injury.
• To determine the optimal parameters for FDA assay accuracy and stability.

Main Methods:

• Cells were cultured in 96-well plates and incubated with FDA.
• Fluorescence microplate analysis was used for detection.
• Optimization of FDA concentration and incubation time was performed.
• Comparison with MTT assay for cell number and H2O2 injury.

Main Results:

• The FDA assay demonstrated a strong correlation (coefficient of 0.99) between fluorescence and cell number within 27-30 minutes.
• Optimal final FDA concentrations ranged from 10-30 μg/ml.
• FDA assay results were equivalent to MTT for general cell viability.
• FDA showed superior sensitivity to MTT for detecting H2O2 injury, especially at higher concentrations, due to shorter assay duration.

Conclusions:

• The FDA microplate assay is a stable, reliable, and feasible method for cell viability detection.
• FDA offers advantages in sensitivity and speed for specific applications like H2O2 injury assessment.
• FDA is a viable alternative to MTT for various cell-based assays.